2021-01-11,Takeda Provides Pipeline Update and Shares Goal to Increase Revenue 50% by FY2030 at the 39th Annual J.P. Morgan Healthcare Conference
2021-01-11,Takeda to Present at The 39th Annual J.P. Morgan Healthcare Conference
2021-01-10,3 Low Price-Book Ratio Stock Picks
2021-01-05,Takeda Completes Sale of Select Non-Core Assets to Cheplapharm
2020-12-27,Billionaire Larry Robbins Top 10 Stock Picks
2020-12-21,Takeda Furthers Innovation-Focused Strategy in China with Sale of Select Non-Core Assets to Hasten for $322 million USD
2020-12-18,U.S. FDA Approves Supplemental New Drug Application for Takedas ICLUSIG® (ponatinib) for Adult Patients with Resistant or Intolerant Chronic-Phase CML
2020-12-17,Is TAK A Good Stock To Buy Now?
2020-12-16,Prime Therapeutics and Takeda agree to outcomes-based arrangement for Hemophilia A treatment ADVATE® [Antihemophilic Factor (Recombinant)]
2020-12-15,"U.S. Food and Drug Administration Accepts New Drug Application for Review, Grants Priority Review for Takedas TAK-721 (budesonide oral suspension) for the Treatment of Eosinophilic Esophagitis"
2020-12-08,Takedas Pipeline Has Potential to Contribute Significantly to Revenue Growth Over Next Decade
2020-12-08,"The Daily Biotech Pulse: ASH Presentations, Axsome's Positive Midstage Readout, Follow-On Offerings"
2020-12-08,Takeda Announces Approval of TAKHZYRO® (lanadelumab) subcutaneous injection in China for the Treatment of Hereditary Angioedema
2020-12-07,"Takeda Presents Real-World Evidence at ASH 2020, Demonstrating Its Long-Standing Commitment to Personalizing Treatments for Rare Bleeding Disorders"
2020-12-04,Y-mAbs and Takeda Announce Exclusive License and Distribution Agreement for DANYELZA® (naxitamab-gqgk) and Omburtamab in Israel
2020-12-04,"The Daily Biotech Pulse: BioCryst's Heredity Angioedema Treatment Clears FDA, Sutro Biopharma Readout, 2 IPOs"
2020-12-04,"New Phase 3 Data Show TAK-620 (maribavir), an Investigational Drug for the Treatment of Transplant Recipients with Refractory/Resistant Cytomegalovirus (CMV) Infections, Meets Primary Endpoint"
2020-12-02,"Takeda Further Enables Hemophilia A Personalized Care With Launch of myPKFiT® Software for ADYNOVATE® [Antihemophilic Factor (Recombinant), PEGylated]"
2020-11-30,Takeda Completes Sale of Select OTC and Non-Core Assets to Celltrion in Asia Pacific
2020-11-30,"World's Leading Life Science Companies Now Enrolling COMMUNITY, A Global, Platform Trial For Hospitalized Patients With COVID-19"
2020-11-30,"COVID R&D Alliance launches trial of Amgen, UCB, Takeda drugs"
2020-11-19,Selling Dog as Mutton: Japan Carriers Dip on Ministers Rebuke
2020-11-16,15 Largest Drug Companies in the World
2020-11-13,Final Results from the Phase 3 HELP Study Open-Label Extension Support TAKHZYRO® (lanadelumab-flyo) Injection as a Long-term Preventive Treatment Option in Patients with Hereditary Angioedema
2020-11-12,Zhongchao Inc. and Takeda Pharmaceutical Expand Scope of Cooperation in China
2020-11-11,Kamada Ltd (KMDA) Q3 2020 Earnings Call Transcript
2020-11-11,OrigiMed and Takeda Announced Partnership to Accelerate R&D and Commercialization of Innovative Medicines
2020-11-09,Takeda to Highlight Research Commitment in Bleeding Disorders and Personalized Care at American Society of Hematology (ASH) Virtual Annual Meeting
2020-11-05,Japan's Takeda eyes new focus on vaccines after OTC asset sales - CEO
2020-11-05,Japan's Takeda eyes new focus on vaccines after OTC asset sales: CEO
2020-11-05,Eligible patients living with rare debilitating genetic disorder are one step closer to having access to first-of-its-kind treatment option
2020-11-05,Takeda Oncology Demonstrates Leadership in Hematologic Cancers at 62nd American Society of Hematology (ASH) Annual Meeting
2020-10-29,"Moderna Third-Quarter Earnings Show Soaring Revenue, R&D Costs"
2020-10-29,"Moderna Q3 Revenues Beat Estimates, Inks Coronavirus Vaccine Supply Deal With Japan"
2020-10-29,"The Daily Biotech Pulse: Novartis Acquires Gene Therapy Company, Moderna's Japanese Vaccine Supply Deal"
2020-10-29,Seqster Partners with Takeda to Help Digitally Transform Patient Experiences
2020-10-29,"Japan's Takeda to import 50 million doses of Moderna's COVID-19 vaccine, raises profit forecast"
2020-10-29,"Takeda FY2020 H1 Results Demonstrate Portfolio Resilience; Confirms Full-Year Management Guidance & Raises Forecasts for Free Cash Flow, Reported OP & Reported EPS"
2020-10-29,Takeda to import and distribute 50 million doses of Moderna's COVID-19 vaccine candidate in Japan
2020-10-29,Takeda Expands COVID-19 Vaccine Supply in Japan Through Partnership with Moderna and Government of Japan
2020-10-27,Takeda Presents Rare Bleeding Disorders Research at Thrombosis & Hemostasis Summit of North America (THSNA) 2020
2020-10-27,Nikkei 225 Indexs Two New Foreign CEOs Shrug Off Ghosns Concerns
2020-10-26,Japan Set for Blockbuster Bonds After NTT Revives M&A Push
2020-10-21,BioLife Plasma Services Announces Opening of First Plasma Collection Center in Nebraska
2020-10-19,"Bristol Myers Squibb, Exelixis Granted FDA Priority Review For Kidney Cancer Treatment"
2020-10-16,Shire Acq Inv Ireland Designated Activity Co -- Moody's announces completion of a periodic review of ratings of Takeda Pharmaceutical Company Limited
2020-10-15,Vertex Tumbles As It Stops Testing On Protein Deficiency Treatment
2020-10-14,Hedge Funds Are Cashing Out Of Takeda Pharmaceutical Company Limited (TAK)
2020-10-14,"Japans Dentsu lobbied for and funded campaign for Tokyo games, documents show, despite Olympics contract"
2020-10-14,"CORRECTED-INSIGHT-Japans Dentsu lobbied for and funded campaign for Tokyo games, documents show, despite Olympics contract"
2020-10-13,Takeda Accelerates Digital Transformation with Accenture and AWS
2020-10-13,"Takeda-Led Group Begins Manufacturing COVID-19 Plasma Treatment, Says Confident Of Efficacy"
2020-10-12,Takeda group begins manufacturing COVID-19 plasma treatment ahead of approval
2020-10-12,Takeda group begins manufacturing COVID-19 plasma treatment ahead of approval
2020-10-12,Safety and Efficacy of Subcutaneous Entyvio® (Vedolizumab) Sustained During Long-term Maintenance Therapy in Adults with Moderately to Severely Active Ulcerative Colitis
2020-10-08,Takeda-led COVID-19 plasma treatment enters clinical trial with first patient
2020-10-08,Takeda-led COVID-19 plasma treatment enters clinical trial with first patient
2020-10-08,"Amgen, Cytokinetics Partnership Disappoints With Data On Heart Treatment"
2020-10-08,ARWR: Collaboration with Takeda for Co-Development and Co-Commercialization for ARO-AAT
2020-10-08,Takeda and Arrowhead Collaborate to Co-Develop and Co-Commercialize ARO-AAT for Alpha-1 Antitrypsin-Associated Liver Disease
2020-09-25,"First and only recombinant von Willebrand factor treatment for adults with von Willebrand Disease, the most common inherited bleeding disorder[1], recommended for routine commissioning via NHS England"
2020-09-18,Foundation Medicine and Takeda Announce Collaboration To Develop FoundationOne®CDx and FoundationOne®Liquid CDx as Companion Diagnostics for Takedas Late-Stage Lung Cancer Portfolio
2020-09-18,Takeda Presents New Data Highlighting Scientific Advancements in Lung Cancer at ESMO Virtual Congress
2020-09-17,Takeda-led COVID-19 plasma product to begin trial this month
2020-09-16,"The Daily Biotech Pulse: Moderna Expands Into Switzerland, Tiziana To Spin Off Testing Unit, Metacrine IPO"
2020-09-16,Takeda to Divest TachoSil® to Corza Health for 350 Million
2020-09-15,Top Pharmaceutical Stocks for Q4 2020
2020-09-15,Takeda Opens New R&D Cell Therapy Manufacturing Facility to Support Expansion of Next-Generation Clinical Programs
2020-09-15,"European Medicines Agency Approves Label Update for HYQVIA® (Human Normal Immunoglobulin 10% and Recombinant Human Hyaluronidase), Expanding its Use to a Broader Group of Patients with Secondary Immunodeficiencies"
2020-09-11,BioLife Plasma Services Announces Opening of First Plasma Collection Center in Metropolitan Detroit
2020-09-09,Takeda Announces Results from Phase 3 Clinical Trial Evaluating NINLARO (ixazomib) in Newly Diagnosed Multiple Myeloma
2020-09-08,Takeda Divests Select Non-Core Assets in Europe to Cheplapharm for Approximately $562 million USD
2020-08-28,Moderna in talks to supply Japan with 40 million doses of COVID-19 vaccine
2020-08-28,"Japan, eyeing Olympics, lines up half-billion doses of COVID-19 vaccine"
2020-08-25,Phase 2 ELEKTRA Study of Soticlestat (TAK-935/OV935) Meets Primary Endpoint Reducing Seizure Frequency in Children with Dravet Syndrome or Lennox-Gastaut Syndrome
2020-08-24,Trump Announces Authorization of Blood Plasma Covid Treatment. The Only Hitch: It Might Not Work.
2020-08-24,Blackstone Agrees to Buy Takeda Pharmaceutical Unit for $2.3 Billion
2020-08-24,Blackstone to acquire Takeda's consumer health care business for $2.3 billion: WSJ
2020-08-24,Takeda To Sell Consumer Health Unit To Blackstone In $2.3B Deal
2020-08-24,Takeda to Sell Consumer Unit to Blackstone for $2.3 Billion
2020-08-24,Blackstone to Buy Takeda Pharmas Japanese Consumer Healthcare Business for $2.29 billion; Target Price $60
2020-08-24,Takeda to sell Japan consumer health unit valued at $2.3 billion to Blackstone
2020-08-24,Takeda to sell Japanese consumer health unit to Blackstone for $2.3 bln
2020-08-19,Blackstone Set To Win Bid For Takedas Consumer Health Unit  Report
2020-08-18,Takeda preparing to sell Japan consumer health unit to Blackstone - Kyodo
2020-08-18,Takeda to sell unit Takeda Consumer Healthcare to Blackstone - Kyodo
2020-08-17,Seres Seeks Approval of First Microbiome Drug
2020-08-12,Kamada Ltd (KMDA) Q2 2020 Earnings Call Transcript
2020-08-12,"Novavax Plunges for a Second Day on Revenue Miss, Vaccine Uncertainty"
2020-08-11,Bankruptcies in Japan Edge Down in July Despite Covid-19
2020-08-10,National Hemophilia Foundation and Takeda Partner with Alex Borstein to Raise Awareness of von Willebrand Disease
2020-08-09,"Novavax Inks Vaccine Deals In Japan, India; Analyst Sees 70% Stock Upside"
2020-08-07,Novavax Partners With Takeda for Japan Output of Covid Drug
2020-08-07,Coronavirus update: NY's Cuomo OKs sending students back to school as vaccine optimism rises
2020-08-07,"Novavax Announces Deals to Sell Covid-19 Vaccine in India, Japan, and Low-Income Countries"
2020-08-07,"The Daily Biotech Pulse: Novavax Vaccine Deals, Trevena Awaits FDA Decision, 2 IPOs"
2020-08-07,Takeda to make Novavax's COVID-19 vaccine candidate in Japan
2020-08-07,Novavax and Takeda Announce Collaboration for Novavax COVID-19 Vaccine Candidate in Japan
2020-08-06,BioLife Plasma Services Announces Opening of First Plasma Collection Center in Louisiana
2020-08-05,Convalescent Plasma Found to Reduce COVID-19 Death Rate in New Study
